HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M A López-Nevot Selected Research

Disease Susceptibility (Diathesis)

1/2020Polymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis.
3/2003A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M A López-Nevot Research Topics

Disease

9Rheumatoid Arthritis
02/2008 - 02/2001
8Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2009 - 01/2003
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2007 - 03/2005
4Celiac Disease (Celiac Sprue)
03/2007 - 12/2002
3Infections
01/2020 - 04/2001
2Disease Susceptibility (Diathesis)
01/2020 - 03/2003
2Autoimmune Diseases (Autoimmune Disease)
09/2007 - 06/2006
2Chagas Disease (American Trypanosomiasis)
04/2002 - 04/2001
1Alopecia Areata
08/2020
1Aspergillosis
01/2020
1Psoriasis (Pustulosis Palmaris et Plantaris)
09/2007
1Tuberculosis (Tuberculoses)
07/2007
1Crohn Disease (Crohn's Disease)
04/2006
1Ulcerative Colitis
04/2006
1Genetic Predisposition to Disease (Genetic Predisposition)
08/2005
1Inflammation (Inflammations)
08/2005
1Carcinoma (Carcinomatosis)
09/2001
1Heart Diseases (Heart Disease)
04/2001

Drug/Important Bio-Agent (IBA)

4micaIBA
08/2020 - 12/2002
3Macrophage Migration-Inhibitory FactorsIBA
07/2007 - 01/2007
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2003 - 04/2002
2Interleukin-23 (Interleukin 23)IBA
09/2007 - 09/2005
2Interleukin-18 (Interleukin 18)IBA
08/2005 - 06/2005
1Proteins (Proteins, Gene)FDA Link
08/2020
1HLA-B Antigens (HLA-B)IBA
08/2020
1Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
03/2009
1Rheumatoid FactorIBA
02/2008
1HLA-DRB1 Chains (HLA DRB1)IBA
02/2008
1cyclic citrullinated peptideIBA
02/2008
1Anti-Citrullinated Protein AntibodiesIBA
02/2008
1AntibodiesIBA
02/2008
1Tuberculin (PPD)IBA
07/2007
1Aspartic Acid (Aspartate)FDA Link
01/2007
1Fc Receptors (Fc Receptor)IBA
09/2006
1Core Binding Factor Alpha 2 SubunitIBA
06/2006
1UbiquitinIBA
06/2006
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
04/2006
1Codon (Codons)IBA
01/2006
1Protein Tyrosine PhosphatasesIBA
10/2005
1Interleukin-12 (IL 12)IBA
09/2005
1Interleukin-12 Receptors (Interleukin 12 Receptor)IBA
09/2005
1Interleukin-12 Subunit p40IBA
09/2005
1Chemokine CCL5IBA
08/2005
1Poly (ADP-Ribose) Polymerase-1IBA
08/2005
1Nuclear Proteins (Protein, Nuclear)IBA
08/2005
1Interleukin-1 (Interleukin 1)IBA
06/2005
1CTLA-4 AntigenIBA
03/2005
1NF-kappa B (NF-kB)IBA
02/2005
1Toll-Like Receptor 2IBA
01/2004
1Poly AIBA
03/2003
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2003
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2003
1NucleotidesIBA
09/2001
1HLA-A Antigens (HLA-A)IBA
09/2001
13' Untranslated Regions (3' UTR)IBA
04/2001
1natural resistance-associated macrophage protein 1IBA
04/2001
1HLA-DQ Antigens (HLA-DQ)IBA
02/2001
1EpitopesIBA
02/2001

Therapy/Procedure

1Transplantation
01/2020
1Drug Therapy (Chemotherapy)
01/2020